Cipta Sarana Medika Tbk. vs Repower Asia Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Repower Asia Indonesia Tbk. trades at Rp50 (market cap 331.68B, 85.51M 24h volume). The key difference: Repower Asia Indonesia Tbk. is far larger — about 2.1× Cipta Sarana Medika Tbk.'s market cap, and Repower Asia Indonesia Tbk. is more actively traded (85.51M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | REAL | |
|---|---|---|
Market Cap | 158.12B | 331.68B |
Volume | 8.21M | 85.51M |
Lot | 82.15K | 855.15K |
Turnover | 515.2M | 4.31B |
Average Price | 62.72 | 50.45 |
Value | 515.2M | 4.31B |
Indicative Equilibrium Price | 63 | 50 |
Indicative Equilibrium Volume | 1.33K | 118 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Repower Asia Indonesia Tbk (the Company) was established based on Notarial Deed No. 04 of Titik Krisna Murti Wikaningsih, S.H., M.KN., dated March 13, 2011, a Notary in Bekasi.
Read more on REAL →